Paper89390
Tolfenamic acid is as effective as ergotamine during migraine attacks.
Hakkarainen H and 3 others. Lancet, 1979. Cited by 112 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Tolfenamic acid is as effective as ergotamine during migraine attacks. Papers, record 89390. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/89390
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ergotamine | Major topic |
| Migraine Disorders | Major topic |
| Prostaglandin Antagonists | Major topic |
| ortho-Aminobenzoates | Major topic |
| Adolescent | |
| Adult | |
| Aspirin | |
| Chemical Phenomena | |
| Chemistry | |
| Clinical Trials as Topic | |
| Consumer Behavior | |
| Double-Blind Method | |
| Drug Evaluation | |
| Female | |
| Humans | |
| Middle Aged | |
| Nausea | |
| Placebos | |
| Vasoconstrictor Agents |
Source PubMed
Cited by24
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 112 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,892,221 | Anticonvulsant potential of tolfenamic acid in pentylenetetrazol-induced acute symptomatic seizures in male wistar rats. | J Physiol Sci | 2026 | https://conductscience.org/library/papers/42892221 | PubMed |
| 40,903,946 | Prostaglandins: Key players in immunomodulation of the nervous system. | Neural Regen Res | 2026 | https://conductscience.org/library/papers/40903946 | PubMed |
| 38,157,876 | The history and rationale of the development of new drugs for migraine treatment. | Arq Neuropsiquiatr | 2023 | https://conductscience.org/library/papers/38157876 | PubMed |
| 28,878,750 | Identification of the Tolfenamic Acid Binding Pocket in PrbP from Liberibacter asiaticus. | Front Microbiol | 2017 | https://conductscience.org/library/papers/28878750 | PubMed |
| 28,421,555 | Pharmacological Agents Affecting Emesis : A Review (Part II). | Drugs | 1992 | https://conductscience.org/library/papers/28421555 | PubMed |
| 27,713,337 | NSAIDs in the Acute Treatment of Migraine: A Review of Clinical and Experimental Data. | Pharmaceuticals (Basel) | 2010 | https://conductscience.org/library/papers/27713337 | PubMed |
| 27,706,811 | Oncogenic targets Mmp7, S100a9, Nppb and Aldh1a3 from transcriptome profiling of FAP and Pirc adenomas are downregulated in response to tumor suppression by Clotam. | Int J Cancer | 2017 | https://conductscience.org/library/papers/27706811 | PubMed |
| 24,462,621 | Tolfenamic acid downregulates BACE1 and protects against lead-induced upregulation of Alzheimer's disease related biomarkers. | Neuropharmacology | 2014 | https://conductscience.org/library/papers/24462621 | PubMed |
| 20,086,170 | Combined treatment of pancreatic cancer with mithramycin A and tolfenamic acid promotes Sp1 degradation and synergistic antitumor activity. | Cancer Res | 2010 | https://conductscience.org/library/papers/20086170 | PubMed |
| 15,222,892 | Rizatriptan versus rizatriptan plus rofecoxib versus rizatriptan plus tolfenamic acid in the acute treatment of migraine. | BMC Neurol | 2004 | https://conductscience.org/library/papers/15222892 | PubMed |
| 12,027,785 | Practical approaches to migraine management. | CNS Drugs | 2002 | https://conductscience.org/library/papers/12027785 | PubMed |
| 8,983,935 | Pharmacokinetics of tolfenamic acid in pediatric patients after single oral dose. | Eur J Drug Metab Pharmacokinet | 1995 | https://conductscience.org/library/papers/8983935 | PubMed |
| 8,838,783 | A review of the treatment of primary headaches. Part I: Migraine. | Ital J Neurol Sci | 1995 | https://conductscience.org/library/papers/8838783 | PubMed |
| 7,238,564 | Human pharmacokinetics of tolfenamic acid, a new anti-inflammatory agent. | Eur J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/7238564 | PubMed |
| 7,166,179 | Human metabolism of tolfenamic acid. II. Structure of metabolites and C-13 NMR assignments of fenamates. | Eur J Drug Metab Pharmacokinet | 1982 | https://conductscience.org/library/papers/7166179 | PubMed |
| 6,991,241 | Migraine: current approach to prevention and treatment. | Drugs | 1980 | https://conductscience.org/library/papers/6991241 | PubMed |
| 6,691,890 | Effects of migraine attack and metoclopramide on the absorption of tolfenamic acid. | Br J Clin Pharmacol | 1984 | https://conductscience.org/library/papers/6691890 | PubMed |
| 6,419,759 | Low bioavailability of ergotamine tartrate after oral and rectal administration in migraine sufferers. | Br J Clin Pharmacol | 1983 | https://conductscience.org/library/papers/6419759 | PubMed |
| 3,899,452 | Clinical pharmacokinetics of ergotamine in migraine and cluster headache. | Clin Pharmacokinet | 1985 | https://conductscience.org/library/papers/3899452 | PubMed |
| 3,876,221 | Pharmacokinetics of tolfenamic acid in patients with cirrhosis of the liver. | Eur J Clin Pharmacol | 1985 | https://conductscience.org/library/papers/3876221 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/89390
GET https://conductscience.org/api/papers/v1/89390/cited_by?page=2